June 2022

Contents

Editorial

• HTB June 2022 (1 June 2022)

Special reports

• Monkeypox outbreak: Update and further information

Conference reports

• 29th Conference on Retroviruses and Opportunistic Infections (CROI 2022): further reports

• CROI 2022: Updates from the VESTED study

• CROI 2022: Switching to dolutegravir for adults on stable PI-based second-line ART

Antiretrovirals

• Lenacapavir in MDR HIV: phase 3 results of CAPELLA study published

• ViiV licenses long-acting cabotegravir (CAB-LA) for generic access

Guidelines

• Draft BHIVA guidelines online for comment: deadline 9 June

mpox

• Monkeypox cases in gay men in the UK: BHIVA and ECDC rapid statements

• Monkeypox DNA in semen supports advice to use condoms for eight weeks after infection has cleared

• Risk of monkeypox becoming endemic in Europe: ECDC assessment

• Seven cases of monkeypox virus in the UK from 2018 to 2021

• Monkeypox: Q&A factsheet

COVID-19

• Implications of SARS-CoV-2 in gut tissue for transmission of COVID-19 and long COVID

PDFs

• HTB: no. 6 (1 June 2022) PDF downloads